/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Karla Lant

Karla Lant

Staff Writer

Latest Stories

Futurism
Updated 11.29.17, 9:53 PM EST on futurism
Experts Weigh in on AI and the Singularity
Futurism
Updated 11.29.17, 9:50 PM EST on futurism
Toxic Byproducts From Farms Are Destroying Our Environment
Futurism
Updated 11.29.17, 9:45 PM EST on futurism
Trump Asks For "Border Wall" Designs. Engineers Create Hilarious (And Useful) Alternative
Futurism
Updated 11.29.17, 9:39 PM EST on futurism
In-Womb Project Reveals Striking Images of Developing Human Brains
Futurism
Updated 11.29.17, 9:23 PM EST on futurism
Tesla Just Formed a Breakthrough Partnership to Make Renewables Affordable
Futurism
Updated 11.19.17, 5:04 PM EST on neoscope
Working Nights Could Be Destroying Your Health
Futurism
Updated 11.15.17, 9:42 PM EST on futurism
A Cheap, Accurate Machine-Learning Microscope Could Help Cut Air Pollution
Futurism
Updated 10.31.17, 2:27 PM EDT on neoscope
Re-engineered Immune System Cells Show Early Promise Against HIV
Futurism
10.22.17, 9:00 AM EDT on neoscope
Lack of Access to Morphine Causes 25 Million People to Die in Pain Every Year
Futurism
Updated 10.19.17, 9:49 AM EDT on neoscope
FDA Approves Radical New Gene-Altering Cancer Treatment
Futurism
10.18.17, 10:20 AM EDT on futurism
Kimbal Musk has a Silicon Valley-Style Plan to Feed America
Futurism
10.17.17, 7:48 PM EDT on futurism
Scientists Just Unlocked the Catalyst for Cancerous Relapse
  • Previous
  • 1
  • ...
  • 48
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.